Background Nanotechnology is considered a new and rapidly emerging area in the
pharmaceutical and medicinal field. Nanoparticles, as drug delivery systems, impart several …

The unique interfacial properties, huge diversity, and biocompatible nature of phospholipids
make them an attractive pharmaceutical excipient. The amphiphilic nature of these …

Poor aqueous solubility of drugs is still a foremost challenge in pharmaceutical product
development. The use of lipids in designing formulations provides an opportunity to …

Cancer is one of the leading causes of death but is surpassed by cardiovascular diseases.
Cancer is a disease categorized by the uncontrolled growth of cells worldwide with an …

The therapeutic efficacy of orally administered drugs is often restricted by their inherent
limited oral bioavailability. Low water solubility, limited permeability through the intestinal …

Temozolomide is a drug approved for treating glioblastomas, which has 100% oral
bioavailability but gets degraded at physiological pH thus having very short half-life and only …

Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an
estimated 17.9 million lives each year, representing one third of global mortality. As existing …

Liposome is a promising carrier system for delivering bioactive molecules. However, the
successful delivery of pH-sensitive molecules is still limited by the intrinsic instability of …

The field of nanomedicine employs novel drug delivery systems (NDDSs) to overcome the
limitations of traditional dosage forms. Conventional formulations are associated with poor …

Various bioactive ingredients have been extracted from Chinese herbal medicines (CHMs)
that affect tumor progression and metastasis. To further understand the mechanisms of …